News

The U.S. Food and Drug Administration made the controversial decision to authorize the sale of Juul e-cigarettes, including ...
Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s ...
In a groundbreaking move, the FDA has approved a new UV light-based process for sanitizing raw milk — one that preserves its ...
Drugmaker Sarepta Therapeutics said late Friday it won't comply with a request from the Food and Drug Administration to halt ...
The FDA's ODAC voted that the benefit-risk profile of belantamab mafodotin in multiple myeloma were not favorable, ...
ATLAS trial investigator Guy Young, MD, Children's Hospital Los Angeles and University of Southern California Keck School of ...
Sarepta rebuffed a call from the Food and Drug Administration to halt all shipments of its gene therapy for Duchenne muscular ...
Aquestive Therapeutics, Inc. (NASDAQ: AQST) ('Aquestive” or the 'Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...
At the FDA's request, delandistrogene moxeparvovec (Elevidys), the only approved gene therapy for Duchenne muscular dystrophy ...
Testosterone propionate was once a common treatment for men with low testosterone. It’s a synthetic version of the naturally ...
Mirdametinib is marketed under the brand name EZMEKLY® in the European Union and is conditionally approved by the European ...
Regulators plan to integrate ibogaine treatment into Colorado’s psychedelic healing industry. Still, the drug faces an uncertain future.